iBio
IBIO
#10063
Rank
A$0.10 B
Marketcap
A$2.02
Share price
2.14%
Change (1 day)
93.16%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.06. In 2025 the company made an earnings per share (EPS) of A-$2.47 an increase over its 2024 EPS that were of A-$9.17.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-52.52%
2025A-$2.47-73.08%
2024A-$9.17-93.88%
2023A-$149.84-8.14%
2022A-$163.1292.67%
2021A-$84.67-80.33%
2020A-$430.39-35.11%
2019A-$663.22-38.96%
2018A-$1,087-6.1%
2017A-$1,15736.67%
2016A-$846.6633.33%
2015A-$635.0050%
2014A-$423.33-53.85%
2013A-$917.22-7.14%
2012A-$987.77-64.1%
2011A-$2,75277.27%
2010A-$1,552144.44%
2009A-$635.0012.93%
2008A-$562.3012.2%
2007A-$501.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.33-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.73-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.88 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$0.24-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA